Literature DB >> 20927128

Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness.

L C Martins1, V N Figueiredo, T Quinaglia, L Boer-Martins, J C Yugar-Toledo, J F V Martin, C Demacq, E Pimenta, D A Calhoun, H Moreno.   

Abstract

Resistant hypertension (RHTN) includes patients whose blood pressure (BP) is controlled with the use of four or more antihypertensive medications, and is referred to as 'controlled resistant hypertension' (CRH). While specifically comparing patients with CRH and uncontrolled resistant hypertension (UCRH), we hoped to identify distinguishing characteristics that would provide insight into factors contributing to resistance to antihypertensive therapies. RHTN patients were identified as controlled (CRH, n=43) or uncontrolled (UCRH, n=47). No statistical differences were observed between the CRH and UCRH subgroups with respect to age and gender. The body mass index, aldosterone-renin ratio and pulse wave velocity (PWV) were significantly higher in UCRH patients. Although both subgroups showed increased cardiac mass, left ventricular mass index was significantly higher in UCRH compared with CRH patients. Multivariate linear regression analysis indicated that PWV was significantly dependent on age in both UCRH and CRH patients; however, the influence of ageing was more pronounced in the former subgroup. Older age, greater vascular stiffness, higher aldosterone levels and greater left ventricular hypertrophy were significantly associated with lack of BP control in patients with RHTN. These findings suggest important possibilities in terms of preventing and better treating RHTN.

Entities:  

Mesh:

Year:  2010        PMID: 20927128     DOI: 10.1038/jhh.2010.95

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  25 in total

Review 1.  Sex differences in mechanisms of arterial stiffness.

Authors:  Jennifer J DuPont; Rachel M Kenney; Ayan R Patel; Iris Z Jaffe
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

Review 2.  Resistant or refractory hypertension: are they different?

Authors:  Rodrigo Modolo; Ana Paula de Faria; Aurélio Almeida; Heitor Moreno
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

3.  Adipokines: another link between obesity and hypertension.

Authors:  A R Sabbatini; A P C de Faria; R Modolo; H Moreno
Journal:  J Hum Hypertens       Date:  2014-04-17       Impact factor: 3.012

4.  Baroreflex gain and vasomotor sympathetic modulation in resistant hypertension.

Authors:  Isabelle Magalhães Guedes Freitas; Leonardo Barbosa de Almeida; Natália Portela Pereira; Pedro Augusto de Carvalho Mira; Rogério Baumgratz de Paula; Daniel Godoy Martinez; Edgar Toschi-Dias; Mateus Camaroti Laterza
Journal:  Clin Auton Res       Date:  2017-04-06       Impact factor: 4.435

5.  Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure.

Authors:  Tanja Dudenbostel; Maria C Acelajado; Roberto Pisoni; Peng Li; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2015-05-18       Impact factor: 10.190

6.  Prescribing patterns in the treatment of hypertension among underserved African American elderly.

Authors:  Hamed Yazdanshenas; Mohsen Bazargan; Gail Orum; Leila Loni; Navid Mahabadi; Baqar Husaini
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

7.  Deregulation of adipokines related to target organ damage on resistant hypertension.

Authors:  A R Sabbatini; A P Faria; N R Barbaro; W M Gordo; R G P Modolo; C Pinho; V Fontana; H Moreno
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

8.  Brazilian Position Statement on Resistant Hypertension - 2020.

Authors:  Juan Carlos Yugar-Toledo; Heitor Moreno Júnior; Miguel Gus; Guido Bernardo Aranha Rosito; Luiz César Nazário Scala; Elizabeth Silaid Muxfeldt; Alexandre Alessi; Andrea Araújo Brandão; Osni Moreira Filho; Audes Diógenes de Magalhães Feitosa; Oswaldo Passarelli Júnior; Dilma do Socorro Moraes de Souza; Celso Amodeo; Weimar Kunz Sebba Barroso; Marco Antônio Mota Gomes; Annelise Machado Gomes de Paiva; Eduardo Costa Duarte Barbosa; Roberto Dischinger Miranda; José Fernando Vilela-Martin; Wilson Nadruz Júnior; Cibele Isaac Saad Rodrigues; Luciano Ferreira Drager; Luiz Aparecido Bortolotto; Fernanda Marciano Consolim-Colombo; Márcio Gonçalves de Sousa; Flávio Antonio de Oliveira Borelli; Sérgio Emanuel Kaiser; Gil Fernando Salles; Maria de Fátima de Azevedo; Lucélia Batista Neves Cunha Magalhães; Rui Manoel Dos Santos Póvoa; Marcus Vinícius Bolívar Malachias; Armando da Rocha Nogueira; Paulo César Brandão Veiga Jardim; Thiago de Souza Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

Review 9.  Controlled Versus Uncontrolled Resistant Hypertension: Are They in the Same Bag?

Authors:  J C Yugar-Toledo; V Brunelli; J F Vilela-Martin; A Fattori; H Moreno
Journal:  Curr Hypertens Rep       Date:  2018-03-27       Impact factor: 5.369

10.  Glycated hemoglobin correlates with arterial stiffness and endothelial dysfunction in patients with resistant hypertension and uncontrolled diabetes mellitus.

Authors:  Beatriz Moreno; Ana Paula de Faria; Alessandra Mileni Versuti Ritter; Lara Buonalumi Tacito Yugar; Silvia Elaine Ferreira-Melo; Rivadavio Amorim; Rodrigo Modolo; André Fattori; Juan Carlos Yugar-Toledo; Antonio Coca; Heitor Moreno
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-05-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.